Financing channel feed – Endpoints News

Financing channel feed

Exclusive: BigHat inks Lilly deal for AI-boosted antibodies, extends Series B

2 months ago

Biotech seed rounds sink to lowest level in years as industry slump drags on

2 months ago

Glycomine raises $115M to see if it can treat rare glycosylation disorder

2 months ago

Attovia collects another $90M for I&I biologics in third funding round in two years

2 months ago

BioNTech-backed ADC maker DualityBio plans IPO on Hong Kong exchange

2 months ago

Exclusive: Cardiometabolic biotech gets $57.5M Series B, with help from Cytokinetics

3 months ago

Market turmoil is tanking biotech M&A and IPOs. Here's the playbook startups will use to survive

3 months ago

Exclusive: Merida Biosciences gets $121M to treat autoimmune and allergy diseases at their roots

3 months ago

Stock market melts down over Trump’s tariffs, and biotech's pain keeps growing

3 months ago

Immunology startup RayThera secures $110M in Series A raise

3 months ago

ADC startup DualityBio seeks Hong Kong IPO amid precarious market

3 months ago

PIPEs, biopharma’s favorite financing vehicle, freeze amid market struggles

3 months ago

Exclusive: Daymark Health launches with $11.5M to care for cancer patients

3 months ago

Exclusive: Neurona bags $102M to treat epilepsy with cell therapy

3 months ago

Atsena gets Bain's support in $150M Series C to thwart blindness with gene therapy

3 months ago

RNA editing startup raises $155M to bring liver and lung disease therapy into clinic

3 months ago

Alphabet’s Isomorphic Labs raises $600M in biotech’s largest round of 2025

3 months ago

Exclusive: SV Health debuts Parkinson's biotech with backing from AbbVie and others

3 months ago

Galatea Bio gets $25M to map genetic diversity of 10 million people, help pharma create new medicines

3 months ago

Ophthalmology startup Character Biosciences gets $93M for genetics-based approach

3 months ago

Another immunology biotech emerges as Hillstar takes flight with $67M

3 months ago

Tempero Bio, led by ex-Novartis execs, gets $70M to reduce substance use disorders

3 months ago

23andMe files for bankruptcy, CEO Wojcicki steps down

3 months ago

Belgian biotech Augustine gets $85M for neuro and cardiometabolic pills

3 months ago

First page Previous page 1 2 345 6 7 Next page Last page